155 related articles for article (PubMed ID: 9231696)
1. Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration.
Pearson JM; Bailie MB; Fink GD; Roth RA
Toxicology; 1997 Sep; 121(3):181-9. PubMed ID: 9231696
[TBL] [Abstract][Full Text] [Related]
2. Platelet activating factor receptor blockade alone or in combination with leukotriene synthesis inhibition does not ameliorate alpha-naphthylisothiocyanate-induced hepatotoxicity.
Bailie MB; Pearson JM; Fink GD; Roth RA
Toxicol Lett; 1996 Feb; 84(2):89-95. PubMed ID: 8614909
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury.
Komatsu Y; Shiratori Y; Hikiba Y; Hashimoto N; Han K; Kawase T; Yoshida H; Okano K; Omata M
Dig Dis Sci; 1996 May; 41(5):1030-7. PubMed ID: 8625746
[TBL] [Abstract][Full Text] [Related]
4. Leukotrienes and alpha-naphthylisothiocyanate-induced liver injury.
Bailie MB; Dahm LJ; Peters-Golden M; Harris RR; Carter GW; Roth RA
Toxicology; 1995 Jun; 100(1-3):139-49. PubMed ID: 7624871
[TBL] [Abstract][Full Text] [Related]
5. Platelet participation in liver injury from gram-negative bacterial lipopolysaccharide in the rat.
Pearson JM; Schultze AE; Jean PA; Roth RA
Shock; 1995 Sep; 4(3):178-86. PubMed ID: 8574752
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium chloride treatment attenuates hepatic platelet accumulation after lipopolysaccharide administration.
Pearson JM; Brown AP; Schultze AE; Ganey PE; Roth RA
Shock; 1996 Jun; 5(6):408-15. PubMed ID: 8799952
[TBL] [Abstract][Full Text] [Related]
7. Involvement of platelet-activating factor in hepatic apoptosis and necrosis in chronic ethanol-fed rats given endotoxin.
Murohisa G; Kobayashi Y; Kawasaki T; Nakamura S; Nakamura H
Liver; 2002 Oct; 22(5):394-403. PubMed ID: 12390475
[TBL] [Abstract][Full Text] [Related]
8. Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells.
Mustafa SB; Flickinger BD; Olson MS
Hepatology; 1999 Nov; 30(5):1206-14. PubMed ID: 10534342
[TBL] [Abstract][Full Text] [Related]
9. Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats.
Sakaguchi T; Nakamura S; Suzuki S; Oda T; Ichiyama A; Baba S; Okamoto T
Hepatology; 1999 Oct; 30(4):959-67. PubMed ID: 10498648
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor.
De Plaen IG; Tan XD; Chang H; Wang L; Remick DG; Hsueh W
Br J Pharmacol; 2000 Jan; 129(2):307-14. PubMed ID: 10694237
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide augments aflatoxin B(1)-induced liver injury through neutrophil-dependent and -independent mechanisms.
Barton CC; Ganey PE; Roth RA
Toxicol Sci; 2000 Nov; 58(1):208-15. PubMed ID: 11053557
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of TNF-alpha from endotoxin-induced nitric oxide and acute-phase hypotension.
Xie J; Joseph KO; Bagby GJ; Giles TD; Greenberg SS
Am J Physiol; 1997 Jul; 273(1 Pt 2):H164-74. PubMed ID: 9249487
[TBL] [Abstract][Full Text] [Related]
14. Thrombin is a distal mediator of lipopolysaccharide-induced liver injury in the rat.
Moulin F; Pearson JM; Schultze AE; Scott MA; Schwartz KA; Davis JM; Ganey PE; Roth RA
J Surg Res; 1996 Oct; 65(2):149-58. PubMed ID: 8903462
[TBL] [Abstract][Full Text] [Related]
15. Primed neutrophils injure rat lung through a platelet-activating factor-dependent mechanism.
Anderson BO; Poggetti RS; Shanley PF; Bensard DD; Pitman JM; Nelson DW; Whitman GJ; Banerjee A; Harken AH
J Surg Res; 1991 May; 50(5):510-4. PubMed ID: 1710005
[TBL] [Abstract][Full Text] [Related]
16. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
17. The involvement of adhesion molecules and lipid mediators in the adhesion of human platelets to eosinophils.
Jawień J; Lomnicka M; Korbut R; Chłopicki S
J Physiol Pharmacol; 2005 Dec; 56(4):637-48. PubMed ID: 16391420
[TBL] [Abstract][Full Text] [Related]
18. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions.
de Lima WT; Sirois P; Jancar S
Eur J Pharmacol; 1992 Mar; 213(1):63-70. PubMed ID: 1323472
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide-induced hepatic injury is enhanced by polychlorinated biphenyls.
Brown AP; Schultze AE; Holdan WL; Buchweitz JP; Roth RA; Ganey PE
Environ Health Perspect; 1996 Jun; 104(6):634-40. PubMed ID: 8793352
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
Chang SW
J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
